MySpaLive’s Compliance and Training Framework
As conversations continue across the medical aesthetics industry regarding claims that Texas has “closed a med spa loophole” in 2026, MySpaLive is issuing a detailed clarification grounded in statutory authority, legislative history, and current Texas Medical Board (TMB) regulations. The organization states that while regulatory language has been updated and reorganized, Texas law governing physician delegation and nonsurgical cosmetic procedures has not undergone a fundamental statutory overhaul.
In recent months, headlines and industry commentary have suggested that sweeping legislative changes dramatically altered how medical spas operate in Texas. According to MySpaLive, these claims misinterpret both legislative outcomes and regulatory updates. The company emphasizes that understanding the distinction between proposed legislation, enacted law, and administrative rule restructuring is critical for aesthetic professionals making business and compliance decisions.
Senate Bill 378: Vetoed and Not Enacted
One of the most frequently cited pieces of legislation in discussions surrounding the issue is Senate Bill 378 (SB 378). The bill was widely referenced in industry headlines as an effort to “close a med spa loophole” in Texas. However, MySpaLive clarifies that SB 378 was vetoed on June 2, 2025, and did not become law.
Because the bill was vetoed, it has no legal effect. Therefore, physician delegation authority under Texas Occupations Code Chapter 157 remains unchanged. Chapter 157 continues to govern the framework under which physicians may delegate certain medical acts to qualified individuals, provided appropriate supervision and standards are met.
MySpaLive notes that confusion surrounding SB 378 has contributed significantly to misconceptions about a supposed statutory “crackdown.” The organization encourages professionals to verify whether proposed bills were enacted before assuming legal changes have occurred.
House Bill 3749 (Jenifer’s Law): Limited Scope
Another law frequently referenced in discussions about 2026 changes is House Bill 3749, commonly known as Jenifer’s Law. This legislation became effective on September 1, 2025.
According to MySpaLive’s clarification, House Bill 3749 applies specifically to elective IV therapy services. The law was designed to address oversight, transparency, and patient safety considerations related to intravenous therapy offerings in non-traditional medical settings.
Importantly, the statute does not modify the legal structure governing cosmetic injections such as neurotoxins or dermal fillers. It does not alter physician delegation standards for aesthetic injectables, nor does it redefine cosmetic injections as outside the practice of medicine.
MySpaLive stresses that conflating IV therapy regulations with injectable aesthetic procedures has led to inaccurate assumptions about broader changes in med spa law.
Texas Medical Board Rule Reorganization
In January 2025, the Texas Medical Board reorganized certain administrative rules. Former Rule 193.17 was moved into 22 TAC Chapter 169 as part of a structural update intended to improve clarity and accessibility.
MySpaLive emphasizes that this reorganization was administrative rather than prohibitive. The changes clarified and consolidated standards relating to:
- Supervision requirements
- Good Faith Examination standards
- Written protocol obligations
- Basic Life Support (BLS) presence
- Transparency and documentation requirements
The updated framework, including Rule 169.26, outlines supervision parameters but does not prohibit compliant delegation of nonsurgical cosmetic procedures.
According to MySpaLive, the rule migration has been mischaracterized in some industry commentary as a substantive policy shift when it was primarily a structural and organizational change within the administrative code.
Current Legal Framework in Texas
Under existing Texas law, several principles remain firmly in place:
Cosmetic injections are the practice of medicine.
Procedures involving neurotoxins and dermal fillers are legally recognized as medical acts.
Physician delegation remains permissible.
Under Chapter 157, physicians may delegate medical acts to qualified and properly trained individuals when statutory requirements are met.
Good Faith Exam requirement.
A Good Faith Examination must be performed before treatment by a licensed MD, DO, PA, or APRN in accordance with state standards.
Supervision standards apply.
Delegation must comply with Rule 169.26, including appropriate oversight and availability.
MySpaLive asserts that none of these core elements have been fundamentally altered by recent legislative or regulatory activity.
Clarification vs. Transformation
The organization characterizes the current regulatory environment not as a transformation but as a clarification. Texas regulators have reinforced existing patient safety and documentation standards without dismantling the delegation model long used in medical aesthetics practices.
For aesthetic professionals, the distinction matters. Misinterpretations can lead to unnecessary operational restructuring, misinformation within the workforce, and confusion among patients.
MySpaLive states that its own training programs are structured around compliance with:
- Chapter 157 delegation standards
- Rule 169 supervision requirements
- Documented Good Faith Exams
- Written protocols
- Emergency preparedness procedures
The company affirms that its curriculum aligns with Texas Medical Board expectations and emphasizes patient safety and regulatory adherence.
Industry Implications
The medical aesthetics sector in Texas continues to grow rapidly, and clarity in regulatory interpretation is essential for responsible expansion. MySpaLive notes that accurate understanding of the law supports:
- Risk management
- Proper physician collaboration
- Informed business planning
- Ethical patient care
Overstating regulatory change can create fear-based decision-making or unnecessary operational limitations. Conversely, underestimating compliance obligations can expose practices to disciplinary risk.
By issuing a formal clarification, MySpaLive aims to provide a neutral, statute-based explanation rather than commentary driven by headlines.
Encouraging Direct Review of the Law
MySpaLive encourages aesthetic professionals, practice owners, and healthcare providers to review:
- The legislative record confirming the veto of SB 378
- The enacted scope of House Bill 3749
- The Texas Occupations Code Chapter 157
- Texas Medical Board Rule 169
The company states that decisions should be based on enacted statutes and official administrative rules rather than summaries circulating online.
For those seeking a detailed statutory breakdown, MySpaLive offers its full legal analysis upon request.
About
MySpaLive concludes by reaffirming its commitment to compliance, transparency, and elevating standards in aesthetic training across Texas. The organization maintains that regulatory clarity ultimately benefits both practitioners and patients.
While regulatory language has evolved and administrative rules have been reorganized, Texas law continues to allow physician-delegated cosmetic procedures within a defined and structured framework.
In the company’s assessment, the 2026 landscape reflects clarification and reinforcement of existing standards—not a fundamental statutory shift.
